Switzerland
Paragon carves out Condecta from Arbonia
Arbonia announced it would sell Condecta in July 2017 after a strategic review
Aurelius carves out Cargill's Swiss animal feed business
Cargill's Swiss division generated revenues of €130m for the financial year ending in March 2017
Partners Group sells 9.33% stake in VAT Group
Further sell-down amounts to CHF 355m and leaves Partners Group with a stake of 3.75%
Argos sells BMF to Rantum, Cedarlake
Bartholet family will retain a minority stake and Roland Bartholet will remain chairman
Auven leads $200m round for ADC Therapeutics
Hedge fund Red Mile, the Wild Family Office and VC Astrazeneca also back the round
Initiative & Finance invests in Bel Air Fine Art
GP is currently investing from Initiative & Finance FPCI II, a €168m fund launched in 2015
Redalpine backs CHF 6m funding round for Lunaphore
Zühlke Ventures, Polytech Ecosystem Ventures and Occident Group also invest in the round
DACH fundraising in rude health
Fundraising reached record levels last year, and H1 2017 picked up from where 2016 left off, with 12 final closes rasing a combined €5.1bn
KKR's SoftwareOne acquires UC Point
SoftwareOne looks to develop its presence in the enterprise communication software market
Partners Group sells 10% VAT Group stake
Partners Group will retain a 13.07% stake in VAT Group after the settlement of the transaction
DACH Fundraising Report 2017
Private equity fundraising in the DACH region, as in the rest of Europe, is seeing continued strength
Jadeberg backs €2m round for CS Group
Firm made the investment using capital from its second growth capital fund MCF II
Swisscom reinvests in Adello
VC also announces Bettina von Kupsch of Swisscom Mobile has joined Adello's board
PE-backed Ameos buys Seeklinik Brunnen
Ameos will invest in the expansion of the clinic's facilities over the next four years
Oakley to shift investment focus from UK to DACH
GP notes in its annual report that geopolitical and economic uncertainty is likely to remain
Renaissance Capital buys JLS Digital
Company's management team will retain a minority stake in the business alongside Renaissance
HTGF in €8m series-B for Amal Therapeutics
Round was co-led by corporate venture players Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn
Capvis makes final exit from VAT Group
Capvis placed the shares with institutional investors through an accelerated book-building
US VC firms invest $7m in Breadwallet
DAS Capital, East Ventures, Globe Advisors and Liberty City Ventures invested in the round
Heliad in CHF 6m series-B for Muume
Lead investor is an anonymous Swiss VC firm, while unnamed business angels also invested
SK Capital reinvests in Archroma via refinancing
Deal for speciality chemicals business comes seven months after GP was reportedly exploring a sale
Cornerstone sells Infoniqa SQL back to management
Deal ends a five-year holding period for Cornerstone, which acquired Infoniqa SQL in 2012
Cross divests Micromacinazione to trade investor Lonza
Fund manager fully exits the Swiss micronisation business after a five-year holding period
Ufenau backs Desperado management buy-in
Acquirer says fragmented gastronomy market offers an optimal situation for expansion